Berenberg raised the firm’s price target on Novo Nordisk to DKK 1,150 from DKK 950 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVO:
- Novo Nordisk Takes Legal Route to Crack Down on Copycat Drugs
- Cantor Fitzgerald biotech/biopharma to hold analyst/industry conference call
- Cantor Fitzgerald biotech/biopharma to hold a luncheon meeting
- Novo Nordisk price target raised to DKK 1,150 from DKK 950 at Berenberg
- Eli Lilly price target raised to $500 from $375 at Berenberg